Basic information Safety Supplier Related

LANATOSIDE B

Basic information Safety Supplier Related

LANATOSIDE B Basic information

Product Name:
LANATOSIDE B
Synonyms:
  • LANATOSIDE B
  • 20(22),5BETA-CARDENOLID-3BETA,14BETA,16BETA-TRIOL 3BETA-[O-BETA-D-GALACTOPYRANOSYL-(1->4)-O-BETA-D-[3-O-ACETYLDIGITOXOPYRANOSYL]-(1->4)-DIGITOXOPYRANOSYL-(1->4)-O-BETA-D-DIGITOXOPYRANOSIDE]
  • Card-20(22)-enolide, 3-[(O-β-D-glucopyranosyl-(1→4)-O-3-O-acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxy-, (3β,5β,16β)-
  • digilanidb
  • digilanideb
  • LANTOSIDEB
CAS:
17575-21-2
MF:
C49H76O20
MW:
985.12
EINECS:
241-545-6
Product Categories:
  • Cardioglycosides & Glycosides
Mol File:
17575-21-2.mol
More
Less

LANATOSIDE B Chemical Properties

Melting point:
245-248°C
alpha 
D20 +36.7° (0.47 g in 25 ml 95% alc); D20 +31.8° (0.25 g in 14.1 ml dioxane)
Boiling point:
741.7°C (rough estimate)
Density 
1.1256 (rough estimate)
refractive index 
1.7630 (estimate)
pka
12.89±0.70(Predicted)
LogP
-0.250 (est)
More
Less

LANATOSIDE B Usage And Synthesis

Uses

Lanatoside B is a novel cardiac glycoside inhibitor acting on sodium-potassium ATPase in vivo.

Purification Methods

Crystallise lanatoside B from MeOH. Its solubility is: 1/20 (MeOH), 1/40 (EtOH), 1/5600 (CHCl3), and is insoluble in H2O. [Stoll et al. Helv Chim Acta 16 1049 1933, Miyatake et al. Chem Pharm Bull Jpn 5 171 1957, Beilstein 18 III/IV 2465.] It is cardiotonic.

LANATOSIDE BSupplier

Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
021-61259108 18621169109
Email
market03@meryer.com
Shanghai Tauto Biotech Co., Ltd.
Tel
021-51320588
Email
tauto@tautobiotech.com
Wuhan ChemFaces Biochemical Co., Ltd.
Tel
18607101326 15172504745
Email
aileen@chemfaces.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Shanghai Jizhi Biochemical Technology Co. Ltd.
Tel
4009004166/18616739031 18616739031
Email
3007523370@qq.com